TSP48572-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K83634925


TSA199577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925


TSA199617-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925


TSA199657-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925


TSA199695-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925


TSA199740-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925


TSA199781-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925


TSA199818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925


TSA199854-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925


TSF406901-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF406902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF406903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF406904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF406905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF406906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF407181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF407182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF407183-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF407184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF407185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF407186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF407470-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF407471-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF407472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF407473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF407474-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF407475-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF407762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF407759-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF407760-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF407761-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF407763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF407764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF408057-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF408052-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF408053-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF408054-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF408055-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF408056-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF408344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF408342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF408341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF408343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF408346-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF408345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF408625-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF408626-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF408627-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF408628-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSF408629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF408630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF408898-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.125 µM for 24.0 h


1 subfactor(s)
TSF408894-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 10.0 µM for 24.0 h


1 subfactor(s)
TSF408899-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.04 µM for 24.0 h


1 subfactor(s)
TSF408895-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 3.33 µM for 24.0 h


1 subfactor(s)
TSF408896-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 1.11 µM for 24.0 h


1 subfactor(s)
TSF408897-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.37 µM for 24.0 h


1 subfactor(s)
TSS406909-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS406910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS406911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS406912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS406913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS406914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS407189-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS407190-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS407191-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS407192-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS407193-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS407194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS407478-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS407479-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS407480-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS407481-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS407482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS407483-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS407770-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS407767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS407768-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS407769-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS407771-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS407772-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS408065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS408060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS408061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS408062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS408063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS408064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS408352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS408350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS408349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS408351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS408354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS408353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS408633-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS408634-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS408635-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS408636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.37 µM for 24.0 h


TSS408637-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS408638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS408906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.125 µM for 24.0 h


TSS408902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 10.0 µM for 24.0 h


TSS408907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.04 µM for 24.0 h


TSS408903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 3.33 µM for 24.0 h


TSS408904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 1.11 µM for 24.0 h


TSS408905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83634925 0.37 µM for 24.0 h



TSP48572 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K83634925 Public


https://clue.io/data/CMap2020#LINCS2020

Experimental design


No experimental design provided

Results


No results provided